Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
10th November 2020 | Al Kraus | 8,000 | Exercise of derivative | $3.45 | $27,600.00 |
10th November 2020 | Al Kraus | 8,000 | Open or private sale | $8.00 | $64,000.00 |
18th August 2020 | Edward Raymond Jones | 4,000 | Exercise of derivative | $3.35 | $13,400.00 |
31st July 2020 | Kathleen P. Bloch | 10,000 | Exercise of derivative | $5.60 | $56,000.00 |
5th May 2020 | Phillip P. Chan | 14,100 | Exercise of derivative | $9.39 | $132,399.00 |
5th May 2020 | Vincent Capponi | 10,123 | Exercise of derivative | $9.26 | $93,738.98 |
27th April 2020 | Vincent Capponi | 10,000 | Exercise of derivative | $2.88 | $28,750.00 |
27th April 2020 | Vincent Capponi | 10,000 | Open or private sale | $10.00 | $100,000.00 |
12th April 2020 | Efthymios Deliargyris | 140,000 | Grant/award etc. | $0.00 | |
10th March 2020 | Vincent Capponi | 4,677 | Open or private sale | $6.00 | $28,062.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 3/10.
CytoSorbents Corp. engages in the research and development of blood purification technology. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.
9th January 2021
20th November 2020